Compare CYRX & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | BRBI |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | Brazil |
| Employees | 1100 | 188 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 383.0M |
| IPO Year | 2008 | N/A |
| Metric | CYRX | BRBI |
|---|---|---|
| Price | $10.66 | $15.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $13.31 | N/A |
| AVG Volume (30 Days) | ★ 393.6K | 3.9K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 4.75% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | $17.24 |
| P/E Ratio | ★ $7.39 | $11.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.31 | $12.54 |
| 52 Week High | $11.45 | $67.01 |
| Indicator | CYRX | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 77.36 | 58.36 |
| Support Level | $9.18 | $13.77 |
| Resistance Level | $11.33 | $16.46 |
| Average True Range (ATR) | 0.41 | 0.29 |
| MACD | 0.18 | 0.06 |
| Stochastic Oscillator | 99.23 | 78.80 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.